Research Programme: small molecule therapeutics - Nine Square Therapeutics
Latest Information Update: 18 Sep 2023
At a glance
- Originator Nine Square Therapeutics
- Class Antiparkinsonians; Small molecules
- Mechanism of Action Parkin protein stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Parkinson's disease